Tapewire

Nasdaq · USD

TNDM

TANDEM DIABETES CARE INC

Export transactions ↓
Tapewire entity
4682
SEC CIK
0001438133
Parsed reports
672

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 15, 2024 Filed Feb 21, 2024 00:27 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · derivative · entry 6

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 812

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:27 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 195 $24.29 $4,736.55
Disclosure

SEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,675

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:27 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 475 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 3

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,870

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:27 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 67 $24.29 $1,627.43
Disclosure

SEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,395

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:27 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000014 · wk-form4_1708475226.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,462

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:28 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 475 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · derivative · entry 6

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,371

Underlying: Common Stock · 475 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:28 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · derivative · entry 5

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 812

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:28 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 162 $24.29 $3,934.98
Disclosure

SEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · nonDerivative · entry 4

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,157

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:28 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 475 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · nonDerivative · entry 3

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,319

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:28 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 56 $24.29 $1,360.24
Disclosure

SEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · nonDerivative · entry 2

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,844

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:28 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000016 · wk-form4_1708475269.xml · nonDerivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:27 UTC
Carpenter RickChief Technology Officer
Exercise / conversionRestricted Stock Unit · Derivative 596 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000015 · wk-form4_1708475253.xml · derivative · entry 3

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,978

Underlying: Common Stock · 596 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:27 UTC
Carpenter RickChief Technology Officer
Tax withholdingCommon Stock 245 $24.29 $5,951.05
Disclosure

SEC source: 0001438133-24-000015 · wk-form4_1708475253.xml · nonDerivative · entry 2

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,840

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:27 UTC
Carpenter RickChief Technology Officer
Exercise / conversionCommon Stock 596 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000015 · wk-form4_1708475253.xml · nonDerivative · entry 1

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 2,236 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · derivative · entry 6

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,182

Underlying: Common Stock · 2,236 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 793 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · derivative · entry 5

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,962

Underlying: Common Stock · 793 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 917 $24.29 $22,273.93
Disclosure

SEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · nonDerivative · entry 4

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,362

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 2,236 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · nonDerivative · entry 3

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 325 $24.29 $7,894.25
Disclosure

SEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · nonDerivative · entry 2

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,043

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 793 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000011 · wk-form4_1708475167.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,368

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC
Hansen Shannon MarieChief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 531 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000010 · wk-form4_1708475152.xml · derivative · entry 4

Hansen Shannon Marie · CIK 0001908267 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,246

Underlying: Common Stock · 531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC
Hansen Shannon MarieChief Legal Officer
Tax withholdingCommon Stock 218 $24.29 $5,295.22
Disclosure

SEC source: 0001438133-24-000010 · wk-form4_1708475152.xml · nonDerivative · entry 2

Hansen Shannon Marie · CIK 0001908267 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,576

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC
Hansen Shannon MarieChief Legal Officer
Exercise / conversionCommon Stock 531 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000010 · wk-form4_1708475152.xml · nonDerivative · entry 1

Hansen Shannon Marie · CIK 0001908267 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,794

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:06 UTC Exercise / conversionRestricted Stock Unit · Derivative 1,070 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000002 · wk-form4_1704747950.xml · derivative · entry 2

Sodhi Rajwant · CIK 0001715325 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,070 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSUs granted on January 4, 2021. The total number of shares subject to the RSU vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSUs granted on January 4, 2021. The total number of shares subject to the RSU vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:06 UTC Exercise / conversionCommon Stock 1,070 $27.66 $29,596.20
Disclosure

SEC source: 0001438133-24-000002 · wk-form4_1704747950.xml · nonDerivative · entry 1

Sodhi Rajwant · CIK 0001715325 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:18 UTC
Novara Mark DavidEVP & CHIEF COMMERCIAL OFFICER
GrantRestricted Stock Unit · Derivative 88,975 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000258 · wk-form4_1703020671.xml · derivative · entry 1

Novara Mark David · CIK 0002000342 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,975

Underlying: Common Stock · 88,975 shares

Expires not disclosed

F1 · security: Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F1 · derivative.exercise_price: Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F2 · derivative.exercise_date: Restricted stock units (RSU) vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F2 · derivative.expiration_date: Restricted stock units (RSU) vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:14 UTC
Carpenter RickChief Technology Officer
Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000257 · wk-form4_1703020435.xml · derivative · entry 3

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,247

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on December 15, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 12/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 12/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:14 UTC
Carpenter RickChief Technology Officer
Tax withholdingCommon Stock 141 $28.63 $4,036.83
Disclosure

SEC source: 0001438133-23-000257 · wk-form4_1703020435.xml · nonDerivative · entry 2

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,489

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:14 UTC
Carpenter RickChief Technology Officer
Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000257 · wk-form4_1703020435.xml · nonDerivative · entry 1

Carpenter Rick · CIK 0001513889 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 16:09 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionRestricted Stock Unit · Derivative 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000247 · wk-form4_1701292166.xml · derivative · entry 3

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 619

Underlying: Common Stock · 310 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 16:09 UTC
Leal JamesChief Manufacturing Officer
Tax withholdingCommon Stock 129 $19.47 $2,511.63
Disclosure

SEC source: 0001438133-23-000247 · wk-form4_1701292166.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,113

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 16:09 UTC
Leal JamesChief Manufacturing Officer
Exercise / conversionCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000247 · wk-form4_1701292166.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,242

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Unit · Derivative 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000246 · wk-form4_1701292152.xml · derivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 745

Underlying: Common Stock · 373 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Tax withholdingCommon Stock 129 $19.47 $2,511.63
Disclosure

SEC source: 0001438133-23-000246 · wk-form4_1701292152.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,805

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC
Gasser Elizabeth AnneEVP, Chief Strategy Officer
Exercise / conversionCommon Stock 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000246 · wk-form4_1701292152.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,934

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:08 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000243 · wk-form4_1701292086.xml · derivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 813

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:08 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 141 $19.47 $2,745.27
Disclosure

SEC source: 0001438133-23-000243 · wk-form4_1701292086.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,299

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:08 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000243 · wk-form4_1701292086.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,440

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:10 UTC
Allen DickDirector
PurchaseCommon Stock 5,000 $18.96 $94,777.50
Disclosure

SEC source: 0001438133-23-000250 · wk-form4_1701292228.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,962

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:10 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000249 · wk-form4_1701292197.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 813

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:10 UTC
BERGER DAVID BEVP & Chief Operating Officer
Tax withholdingCommon Stock 141 $19.47 $2,745.27
Disclosure

SEC source: 0001438133-23-000249 · wk-form4_1701292197.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,338

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:10 UTC
BERGER DAVID BEVP & Chief Operating Officer
Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000249 · wk-form4_1701292197.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 820 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000248 · wk-form4_1701292178.xml · derivative · entry 3

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,639

Underlying: Common Stock · 820 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 284 $19.47 $5,529.48
Disclosure

SEC source: 0001438133-23-000248 · wk-form4_1701292178.xml · nonDerivative · entry 2

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,575

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 820 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000248 · wk-form4_1701292178.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,859

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000245 · wk-form4_1701292127.xml · derivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 813

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Tax withholdingCommon Stock 135 $19.47 $2,628.45
Disclosure

SEC source: 0001438133-23-000245 · wk-form4_1701292127.xml · nonDerivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,622

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000245 · wk-form4_1701292127.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:08 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000244 · wk-form4_1701292109.xml · derivative · entry 3

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 813

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:08 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 116 $19.47 $2,258.52
Disclosure

SEC source: 0001438133-23-000244 · wk-form4_1701292109.xml · nonDerivative · entry 2

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,737

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.